Manohar Lal directs Fast-track Project Implementation & Strengthening of Swachhata (See 'Corp Brief') MSDE in collaboration with UP Govt organises PM-SETU Industry Conclave in Lucknow (See 'Corp Brief') MoS holds interaction with delegation of Armed Forces HQ Association (See 'Corp Brief') NBA disburses Rs 5.68 Crore in Benefit-Sharing Funds for Biodiversity Conservation (See 'Corp Brief') Commerce Secretary Rajesh Agrawal Leads 4th India-Argentina JTC Meeting (See 'Corp Brief') IBC - Sale certificate issued by liquidator under insolvency proceedings in respect of property sold by public auction is not compulsorily registrable: HC (See 'Legal Desk') CBN seizes 66.80 lakh psychotropic tablets in major inter-state pharmaceutical diversion case (See 'Corp Brief') Acquire knowledge, question injustice through constitutional means: RM tells youth (See 'Corp Brief') Empowering mother can enable early identification of disability in child: MoS (See 'Corp Brief') MoS lays Foundation Stone of PMGSY Roads Worth Rs 1,503 Crore in Jammu (See 'Corp Brief') Companies Act - Corporate name change is merely alteration of MoA that preserves company's continuous legal identity, rights, liabilities & obligations without creating a new entity or dissolving the old one: HC (See 'Legal Desk') MCA convenes 'Tech for Professionals' Workshop (See 'Corp Brief') Joshi to inaugurate New Testing Facilities at Jakkuru Campus (See 'Corp Brief') IPR - In action for passing off involving composite trademarks, anti-dissection rule is paramount: HC (See 'Legal Desk') Good Corporate Governance Is Central to India's Development: MoS (See 'Corp Brief') CTTC Bhubaneswar trains Over 8,000 Engineering Students Through Summer Internship (See 'Corp Brief') Trade Mark - Mocha vs Mocha Kaffee - Injunction granted on use of deceptively similar and phonetically similar trade mark - prima facie case is made out that latter mark intents to ride on strong goodwill & reputation of the former: HC (See 'Legal Desk') PARIVARTAN Scheme gains momentum: 1,300+ beneficiaries registered (See 'Corp Brief') Self-Help Groups have become backbone of rural transformation: Chouhan (See 'Corp Brief') IBC - Violation of the principles of natural justice cannot be alleged when a financial institution denies an extension of time under circumstances marked by deliberate dilatory tactics: HC (See 'Legal Desk') HM inaugurates 'Gujarat Gaurav Sarovar' in Amreli, Gujarat (See 'Corp Brief') Chouhan joins Khelo India Samvaad at Mata Sundari College in Delhi (See 'Corp Brief') Limitation - Sufficient cause u/s 5 cannot be construed so liberally as to condone gross negligence, prolonged inaction or lack of bona fide - discretion to condone delay be exercised judicially rather than on sympathetic considerations: HC (See 'Legal Desk') SIDBI organizes conclave of Heads of RRBs for MSME Co-Lending arrangement (See 'Corp Brief') Prasada strengthens India-Morocco Economic Partnership (See 'Corp Brief') IPR - Without solid proof of 'deceptive similarity' or established market 'goodwill,' brand owner cannot restrain competitor from using common descriptive words or distinct symbols: HC (See 'Legal Desk') India, Seychelles hold Bilateral Meeting to strengthen Strategic Cooperation in Fisheries (See 'Corp Brief') IPR - Applicant may correct or amend trademark application so long as change does not amount to substantial alteration of mark originally applied for: HC (See 'Legal Desk') Tete-a-tete around AI in banking sector often begins with algorithms (See CORP EINSICHT)

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.